Qube Research & Technologies Ltd - PRECIGEN INC ownership

PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 158 filers reported holding PRECIGEN INC in Q1 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of PRECIGEN INC
ValueSharesWeighting
Q4 2022$17,529
-77.5%
11,532
-80.1%
0.00%
-100.0%
Q2 2022$78,000
-93.8%
57,921
-90.3%
0.00%
-90.9%
Q1 2022$1,263,000
+351.1%
598,686
+693.4%
0.01%
+450.0%
Q4 2021$280,000
-43.0%
75,459
-23.4%
0.00%
-66.7%
Q3 2021$491,000
+350.5%
98,454
+491.0%
0.01%
+500.0%
Q2 2021$109,000
-70.8%
16,658
-69.2%
0.00%
-83.3%
Q1 2021$373,00054,1020.01%
Other shareholders
PRECIGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
Patient Capital Management, LLC 11,243,560$12,930,0930.72%
IRIDIAN ASSET MANAGEMENT LLC/CT 3,333,468$3,833,4880.36%
First Washington CORP 592,975$681,9210.30%
Fore Capital, LLC 490,000$563,5000.26%
EMFO, LLC 180,000$207,0000.19%
MSD Partners, L.P. 960,000$1,104,0000.10%
SANDERS MORRIS HARRIS LLC 325,000$373,7500.08%
Virtus ETF Advisers LLC 87,692$100,8460.06%
XTX Topco Ltd 263,046$302,5030.05%
CHIRON CAPITAL MANAGEMENT, LLC 45,906$52,7920.04%
View complete list of PRECIGEN INC shareholders